Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study

The Lancet Infectious Diseases

Volumn 17, Issue 2, 2017, Pages 153-163

  Grundmann, Hajo ^a,b   Glasner, Corinna ^b,c   Albiger, Barbara ^d   Aanensen, David M ^c,e   Tomlinson, Chris T ^e   Andrasević, Arjana Tambić ^f   Cantón, Rafael ^g,h   Carmeli, Yehuda ^i,x   Friedrich, Alexander W ^b   Giske, Christian G ^j,k,x   Glupczynski, Youri ^l,x   Gniadkowski, Marek ^m   Livermore, David M ^n,o   Nordmann, Patrice ^p,q   Poirel, Laurent ^p,q   Rossolini, Gian M ^r,s   Seifert, Harald ^t,u   Vatopoulos, Alkiviadis ^v,x   Walsh, Timothy ^w   Woodford, Neil ^n,x   Monnet, Dominique L ^d   Apfalter, Petra ^x   Hartl, Rainer ^x   Huang, Te Din ^x   Strateva, Tanya ^x   Marteva Proevska, Yuliya ^x   Andraševic, Arjana Tambic ^x   Butic, Iva ^x   Pieridou Bagatzouni, Despo ^x   Maikanti Charalampous, Panagiota ^x   Hrabak, Jaroslav ^x   Zemlickova, Helena ^x   Hammerum, Anette ^x   Jakobsen, Lotte ^x   Ivanova, Marina ^x   Pavelkovich, Anastasia ^x   Jalava, Jari ^x   Österblad, Monica ^x   Vaux, Sophie ^x   Dortet, Laurent ^x   Kaase, Martin ^x   Gatermann, Sören G ^x   Tryfinopoulou, Kyriaki ^x   Tóth, Ákos ^x   Jánvári, Laura ^x   Boo, Teck Wee ^x   McGrath, Elaine ^x   Pantosti, Annalisa ^x   Monaco, Monica ^x   Balode, Arta ^x   Saule, Mara ^x   Miciuleviciene, Jolanta ^x   Mierauskaite, Aiste ^x   Perrin Weniger, Monique ^x   Reichert, Paul ^x   Nestorova, Nina ^x   Debattista, Sonia ^x   Zabicka, Dorota ^x   Literacka, Elzbieta ^x   Caniça, Manuela ^x   Manageiro, Vera ^x   Damian, Maria ^x   Lixandru, Brandusa ^x   Nikš, Milan ^x   Schreterova, Eva ^x   Pirš, Mateja ^x   Cerar, Tjaša ^x   Oteo, Jesús ^x   Aracil, Belén ^x   Sjöström, Karin ^x   Hopkins, Katie ^x   Wiuff, Camilla ^x   Brown, Derek J ^x   Hardarson, Hordur ^x   Samuelsen, Ørjan ^x   Haldorsen, Bjørg ^x   Koraqi, Andi ^x   Lacej, Denada ^x   Raka, Lul ^x   Kurti, Arsim ^x   Mijovic, Gordana ^x   Lopicic, Milena ^x   Jelesic, Zora ^x   Trudic, Anika ^x   Kraftandzieva, Ana ^x   Trajkovska Dokic, Elena ^x   Gür, Deniz ^x   Cakar, Asli ^x   Adler, Amos ^x   more..

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^d EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

^f Croatia   (Croatia)

^g HOSPITAL RAMÓN Y CAJAL   (Spain)

^h CSIC   (Spain)

ⁱ TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^j KAROLINSKA INSTITUTE   (Sweden)

^k KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^l UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^m NATIONAL MEDICINES INSTITUTE   (Poland)

ⁿ PUBLIC HEALTH ENGLAND   (United Kingdom)

^o UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^p Associated French National Reference Center for Antibiotic Resistance: Carbapenemase producing Enterobacteriaceae   (France)

^q UNIVERSITY OF FRIBOURG   (Switzerland)

^r UNIVERSITY OF SIENA   (Italy)

^s CAREGGI UNIVERSITY HOSPITAL   (Italy)

^t UNIVERSITY OF COLOGNE   (Germany)

^u HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^v NATIONAL SCHOOL OF PUBLIC HEALTH   (Greece)

^w CARDIFF UNIVERSITY   (United Kingdom)

^x NONE   (Israel)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; BALKAN PENINSULA; CARBAPENEMASE PRODUCING ENTEROBACTERIACEAE; CARBAPENEMASE PRODUCING ESCHERICHIA COLI; CARBAPENEMASE PRODUCING KLEBSIELLA PNEUMONIAE; ESCHERICHIA COLI; HOSPITAL ADMISSION; INCIDENCE; INFECTION CONTROL; KLEBSIELLA PNEUMONIAE; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SOUTHERN EUROPE; ENZYMOLOGY; ESCHERICHIA COLI INFECTION; EUROPE; GENETICS; HUMAN; ISOLATION AND PURIFICATION; KLEBSIELLA INFECTION; MICROBIOLOGY; QUESTIONNAIRE;

ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE; CARBAPENEMASE;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; DRUG RESISTANCE, MICROBIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; EUROPE; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; PREVALENCE; PROSPECTIVE STUDIES; SURVEYS AND QUESTIONNAIRES;

EID: 85006957610     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(16)30257-2     Document Type: Article

References (24)

1. Nordmann, P, Naas, T, Poirel, L, Global spread of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis 17 (2011), 1791–1798.
2. Monaco, M, Giani, T, Raffone, M, et al. Colistin resistance superimposed to endemic carbapenem-resistant Klebsiella pneumoniae: a rapidly evolving problem in Italy, November 2013 to April 2014. Euro Surveill, 19, 2014 PII:20939.
3. Livermore, DM, Warner, M, Jamrozy, D, et al. In vitro selection of ceftazidime-avibactam resistance in Enterobacteriaceae with KPC-3 carbapenemase. Antimicrob Agents Chemother 59 (2015), 5324–5330.
4. Alm, RA, Johnstone, MR, Lahiri, SD, Characterization of Escherichia coli NDM isolates with decreased susceptibility to aztreonam/avibactam: role of a novel insertion in PBP3. J Antimicrob Chemother 70 (2015), 1420–1428.
5. Glasner, C, Albiger, B, Buist, G, et al. Carbapenemase-producing Enterobacteriaceae in Europe: a survey among national experts from 39 countries, February 2013. Euro Surveill, 18, 2013 PII:20525.
6. European Committee on Antimicrobial Susceptibility Testing (EUCAST). EUCAST guidelines for detection of resistance mechanisms and specific resistances of clinical and/or epidemiological importance. Version 1.0, December 2013. http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Resistance_mechanisms/EUCAST_detection_of_resistance_mechanisms_v1.0_20131211.pdf (accessed March 1, 2016).
7. Nordmann, P, Poirel, L, Dortet, L, Rapid Detection of Carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis 18 (2012), 1503–1507.
8. Decision number 2119/98/EC of the European Parliament and of the Council of 24 September 1998: setting up a network for the epidemiological surveillance and control of communicable diseases in the Community. 1998; 1–6. http://eur-lex.europa.eu/resource.html?uri=cellar:293fab95-972a-4d0c-ba28-45d9055fe1a3.0008.02/DOC_1andformat=PDF (accessed March 1, 2015).
9. Commission decision of 22 December 1999 on the communicable diseases to be progressively covered by the Community network under Decision No 2119/98/EC of the European Parliament and of the Council (2000/96/EC). http://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32000D0096andrid=9, 1998 (accessed March 1, 2015).
10. Giakoupi, P, Maltezou, H, Polemis, M, et al. KPC-2-producing Klebsiella pneumoniae infections in Greek hospitals are mainly due to a hyperepidemic clone. Euro Surveill, 14, 2009 PII:19218.
11. Schwaber, MJ, Lev, B, Israeli, A, et al. Containment of a country-wide outbreak of carbapenem-resistant Klebsiella pneumoniae in Israeli hospitals via a nationally implemented intervention. Clin Infect Dis 52 (2011), 848–855.
12. Hasan, CM, Turlej-Rogacka, A, Vatopoulos, AC, Giakkoupi, P, Maâtallah, M, Giske, CG, Dissemination of blaVIM in Greece at the peak of the epidemic of 2005–2006: clonal expansion of Klebsiella pneumoniae clonal complex 147. Clin Microbiol Infect 20 (2014), 34–37.
13. Samra, Z, Ofir, O, Lishtzinsky, Y, Madar-Shapiro, L, Bishara, J, Outbreak of carbapenem-resistant Klebsiella pneumoniae producing KPC-3 in a tertiary medical centre in Israel. Int J Antimicrob Agents 30 (2007), 525–529.
14. Sisto, A, D'Ancona, F, Meledandri, M, et al. Carbapenem non-susceptible Klebsiella pneumoniae from Micronet network hospitals, Italy, 2009 to 2012. Euro Surveill, 17, 2012 PII:20247.
15. Oteo, J, Ortega, A, Bartolomé, R, et al. Prospective multicenter study of carbapenemase-producing Enterobacteriaceae from 83 hospitals in Spain reveals high in vitro susceptibility to colistin and meropenem. Antimicrob Agents Chemother 59 (2015), 3406–3412.
16. Albiger, B, Glasner, C, Struelens, MJ, Grundmann, H, Monnet, DL, the European Survey of Carbapenemase-Producing Enterobacteriaceae (EuSCAPE) working group. Carbapenemase-producing Enterobacteriaceae in Europe: assessment by national experts from 38 countries, May 2015. Euro Surveill 20 (2015), 30062–30068.
17. Izdebski, R, Baraniak, A, Herda, M, et al. MLST reveals potentially high-risk international clones of Enterobacter cloacae. J Antimicrob Chemother 70 (2015), 48–56.
18. Giakkoupi, P, Xanthaki, A, Kanelopoulou, M, et al. VIM-1 Metallo-beta-lactamase-producing Klebsiella pneumoniae strains in Greek hospitals. J Clin Microbiol 41 (2003), 3893–3896.
19. Nordmann, P, Poirel, L, Walsh, TR, Livermore, DM, The emerging NDM carbapenemases. Trends Microbiol 19 (2011), 588–595.
20. Lixandru, BE, Cotar, AI, Straut, M, et al. Carbapenemase-producing Klebsiella pneumoniae in Romania: a six-month survey. PLoS One, 10, 2015, e0143214.
21. Meletis, G, Oustas, E, Bagkeri, M, Carbapenemase reports from the Balkans: a systematic review. Infez Med 22 (2014), 85–106.
22. Magiorakos, AP, Srinivasan, A, Carey, RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18 (2014), 268–281.
23. Lee, GC, Burgess, DS, Treatment of Klebsiella pneumoniae carbapenemase (KPC) infections: a review of published case series and case reports. Ann Clin Microbiol Antimicrob 11 (2012), 1–9.
24. Tumbarello, M, Viale, P, Viscoli, C, et al. Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K pneumoniae: importance of combination therapy. Clin Infect Dis 55 (2012), 943–950.